Cecilia Furlong
Stock Analyst at Morgan Stanley
(1.37)
# 3,485
Out of 5,182 analysts
177
Total ratings
41.33%
Success rate
-3.12%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Cecilia Furlong
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SGHT Sight Sciences | Maintains: Equal-Weight | $6 → $8 | $4.32 | +85.19% | 18 | Dec 2, 2025 | |
| IRTC iRhythm Holdings | Maintains: Overweight | $195 → $205 | $125.96 | +62.75% | 18 | Dec 2, 2025 | |
| MDT Medtronic | Maintains: Overweight | $107 → $117 | $82.92 | +41.10% | 11 | Nov 19, 2025 | |
| ZBH Zimmer Biomet Holdings | Maintains: Equal-Weight | $115 → $95 | $92.59 | +2.60% | 12 | May 6, 2025 | |
| ISRG Intuitive Surgical | Upgrades: Overweight | $522 → $650 | $470.99 | +38.01% | 13 | Dec 2, 2024 | |
| EMBC Embecta | Maintains: Underweight | $13 → $12 | $9.21 | +30.29% | 12 | Jul 15, 2024 | |
| TMDX TransMedics Group | Maintains: Equal-Weight | $75 → $95 | $108.12 | -12.13% | 12 | Feb 28, 2024 | |
| ALC Alcon | Maintains: Equal-Weight | $78 → $85 | $76.01 | +11.83% | 9 | May 11, 2023 | |
| AORT Artivion | Maintains: Equal-Weight | $14 → $15 | $37.03 | -59.49% | 4 | May 8, 2023 | |
| PODD Insulet | Maintains: Equal-Weight | $325 → $343 | $188.31 | +82.15% | 3 | May 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $11 → $14 | $1.28 | +993.75% | 7 | May 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $44 → $48 | $18.49 | +159.60% | 4 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $95 → $102 | $83.46 | +22.21% | 8 | Apr 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $56 → $58 | $59.95 | -3.25% | 17 | Apr 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $18 → $20 | $15.88 | +25.94% | 5 | Feb 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $117 → $131 | $61.41 | +113.32% | 7 | Jan 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $117 → $133 | $92.80 | +43.32% | 11 | Jan 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $270 → $220 | $329.01 | -33.13% | 4 | Jul 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $383 → $378 | $135.07 | +179.85% | 2 | Feb 25, 2022 |
Sight Sciences
Dec 2, 2025
Maintains: Equal-Weight
Price Target: $6 → $8
Current: $4.32
Upside: +85.19%
iRhythm Holdings
Dec 2, 2025
Maintains: Overweight
Price Target: $195 → $205
Current: $125.96
Upside: +62.75%
Medtronic
Nov 19, 2025
Maintains: Overweight
Price Target: $107 → $117
Current: $82.92
Upside: +41.10%
Zimmer Biomet Holdings
May 6, 2025
Maintains: Equal-Weight
Price Target: $115 → $95
Current: $92.59
Upside: +2.60%
Intuitive Surgical
Dec 2, 2024
Upgrades: Overweight
Price Target: $522 → $650
Current: $470.99
Upside: +38.01%
Embecta
Jul 15, 2024
Maintains: Underweight
Price Target: $13 → $12
Current: $9.21
Upside: +30.29%
TransMedics Group
Feb 28, 2024
Maintains: Equal-Weight
Price Target: $75 → $95
Current: $108.12
Upside: -12.13%
Alcon
May 11, 2023
Maintains: Equal-Weight
Price Target: $78 → $85
Current: $76.01
Upside: +11.83%
Artivion
May 8, 2023
Maintains: Equal-Weight
Price Target: $14 → $15
Current: $37.03
Upside: -59.49%
Insulet
May 5, 2023
Maintains: Equal-Weight
Price Target: $325 → $343
Current: $188.31
Upside: +82.15%
May 3, 2023
Maintains: Equal-Weight
Price Target: $11 → $14
Current: $1.28
Upside: +993.75%
Apr 28, 2023
Maintains: Equal-Weight
Price Target: $44 → $48
Current: $18.49
Upside: +159.60%
Apr 27, 2023
Maintains: Overweight
Price Target: $95 → $102
Current: $83.46
Upside: +22.21%
Apr 27, 2023
Maintains: Overweight
Price Target: $56 → $58
Current: $59.95
Upside: -3.25%
Feb 23, 2023
Maintains: Equal-Weight
Price Target: $18 → $20
Current: $15.88
Upside: +25.94%
Jan 6, 2023
Maintains: Equal-Weight
Price Target: $117 → $131
Current: $61.41
Upside: +113.32%
Jan 6, 2023
Maintains: Overweight
Price Target: $117 → $133
Current: $92.80
Upside: +43.32%
Jul 15, 2022
Maintains: Equal-Weight
Price Target: $270 → $220
Current: $329.01
Upside: -33.13%
Feb 25, 2022
Maintains: Equal-Weight
Price Target: $383 → $378
Current: $135.07
Upside: +179.85%